In Vivo Cellular and Molecular Imaging Laboratory (ICMI), VUB, Brussels, Belgium.
Affibody AB, Solna, Sweden.
J Nucl Med. 2018 Jun;59(6):885-891. doi: 10.2967/jnumed.117.199901. Epub 2018 Mar 15.
Imaging of expression of therapeutic targets may enable stratification of patients for targeted treatments. The use of small radiolabeled probes based on the heavy-chain variable region of heavy-chain-only immunoglobulins or nonimmunoglobulin scaffolds permits rapid localization of radiotracers in tumors and rapid clearance from normal tissues. This makes high-contrast imaging possible on the day of injection. This mini review focuses on small proteins for radionuclide-based imaging that would allow same-day imaging, with the emphasis on clinical applications and promising preclinical developments within the field of oncology.
治疗靶点的影像学表现可以实现对靶向治疗患者的分层。使用基于重链仅有免疫球蛋白或非免疫球蛋白支架的重链可变区的小型放射性标记探针,可以使放射性示踪剂在肿瘤中快速定位,并从正常组织中快速清除。这使得在注射当天即可进行高对比度成像成为可能。本迷你综述重点介绍了基于放射性核素的用于当天成像的小型蛋白质,重点介绍了肿瘤学领域的临床应用和有前途的临床前进展。